The evaluation of exposure to hepatitis A virus in HBsAg-positive persons: A multicentre study from Turkey

Basit Öğe Kaydı
dc.authorscopusid9335452300
dc.authorscopusid55816781000
dc.authorscopusid24480152400
dc.authorscopusid23996235800
dc.authorscopusid37081982300
dc.authorscopusid56651969500
dc.authorscopusid6602163658
dc.contributor.authorÇelen, M.K.
dc.contributor.authorTürker, K.
dc.contributor.authorÖztoprak, N.
dc.contributor.authorŞener, A.
dc.contributor.authorTuna, N.
dc.contributor.authorİnce, N.
dc.contributor.authorTabak, F.
dc.contributor.authorErdem, İlhan
dc.date.accessioned2022-05-11T14:37:22Z
dc.date.available2022-05-11T14:37:22Z
dc.date.issued2014
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Enfeksiyon Hastalıkları Ana Bilim Dalı
dc.description.abstractChronic hepatitis B is a major public health problem in our country. Hepatitis A vaccination in HBV carriers who did not encounter with Hepatitis A virus is also significant. We aimed to evaluate the rate of exposure to HAV in HBsAg-positive persons, and the distribution of seronegative individuals according to age groups. Medical records of 4793 patients from 14 centers who were positive for hepatitis B surface antigen (HBsAg). A total 3514 cases (73.3%) were male and 1279 (26.7) were female. The HBsAg positive patients who were previously tested for HAV IgG at the time of firstly admitted to a center. HBsAg positive patients who were previously not tested for HAV IgG were tested and these . patients were confirmed serologically for HAV. The distribution of cases according to age were determined. In this study, 4793 HBsAg-positive patients were evaluated. The ratio of testing of anti-HAV IgG was very low during the first visit (54.2%). Seronegativity was highest in the age group under 19 years of age (26.2%) followed by 20-25 age group (15.5%) and 26-29 age group (12.5%). Testing of HAV serology should not be ignored in especially HBsAg-positive young adults and seronegative young adults should be vaccinated.
dc.identifier.endpage3068
dc.identifier.issn0973-7510
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-84908208023
dc.identifier.scopusqualityQ4
dc.identifier.startpage3063
dc.identifier.urihttps://hdl.handle.net/20.500.11776/8672
dc.identifier.volume8
dc.indekslendigikaynakScopus
dc.institutionauthorErdem, İlhan
dc.language.isoen
dc.publisherJournal of Pure and Applied Microbiology
dc.relation.ispartofJournal of Pure and Applied Microbiology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAnti-HAV IgG
dc.subjectHBsAg
dc.subjectHepatitis A
dc.subjecthepatitis B surface antigen
dc.subjectimmunoglobulin G
dc.subjectadult
dc.subjectaged
dc.subjectArticle
dc.subjectfemale
dc.subjectgroups by age
dc.subjecthepatitis A
dc.subjectHepatitis A virus
dc.subjecthuman
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmedical record
dc.subjectmulticenter study
dc.subjectprevalence
dc.subjectretrospective study
dc.subjectserology
dc.subjectTurkey (republic)
dc.subjectvaccination
dc.titleThe evaluation of exposure to hepatitis A virus in HBsAg-positive persons: A multicentre study from Turkey
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
8672.pdf
Boyut:
85.94 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
Tıp Fakültesi Koleksiyonu